BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 17340591)

  • 1. Late toxicity and biochemical recurrence after external-beam radiotherapy combined with permanent-source prostate brachytherapy: analysis of Radiation Therapy Oncology Group study 0019.
    Lee WR; Bae K; Lawton C; Gillin M; Morton G; Firat S; Baikadi M; Kuettel M; Greven K; Sandler H
    Cancer; 2007 Apr; 109(8):1506-12. PubMed ID: 17340591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
    Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
    Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity effect of the time gap between supplemental beam radiation and Pd-103 prostate brachytherapy.
    Corriveau J; Wallner K; Merrick G; True L; Cavanagh W; Sutlief S; Butler W
    Brachytherapy; 2003; 2(2):108-13. PubMed ID: 15062149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Repeated radiotherapy in locally recurrent nasopharyngeal cancer].
    Lengyel E; Baricza K; Somogyi A; Olajos J; Pápai Z; Gödény M; Németh G; Esik O
    Orv Hetil; 2002 Oct; 143(41):2343-50. PubMed ID: 12434736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [I125 prostate brachytherapy--short-term results of the first 150 patients in Israel].
    Matzkin H; Kaver I; Stenger A; Agai R; Esna N; Merimsky O
    Harefuah; 2001 Aug; 140(8):694-8, 807. PubMed ID: 11547468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for patients with superficial esophageal carcinoma.
    Nishimura Y; Okuno Y; Ono K; Mitsumori M; Nagata Y; Hiraoka M
    Cancer; 1999 Jul; 86(2):220-8. PubMed ID: 10421257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal function following brachytherapy with or without supplemental external beam radiation: results of two prospective randomized trials.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Kurko B; Cleavinger S
    Brachytherapy; 2003; 2(3):147-57. PubMed ID: 15062137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose rate brachytherapy of prostatic adenocarcinoma in combination with external beam radiotherapy a long-term follow-up of the first 50 patients at one center.
    Lennernäs B; Holmäng S; Hedelin H
    Strahlenther Onkol; 2002 Oct; 178(10):537-41. PubMed ID: 12386784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose rate iridium192 afterloading therapy in combination with external beam irradiation for localized prostate cancer.
    Deger S; Dinges S; Roigas J; Schnorr D; Turk I; Budach V; Hinkelbein W; Loening SA
    Tech Urol; 1997; 3(4):190-4. PubMed ID: 9531101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809.
    Hurwitz MD; Halabi S; Archer L; McGinnis LS; Kuettel MR; DiBiase SJ; Small EJ
    Cancer; 2011 Dec; 117(24):5579-88. PubMed ID: 22535500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic options for localized carcinoma of the prostate: the role of external beam radiation therapy.
    Khil MS; Kim JH
    Henry Ford Hosp Med J; 1992; 40(1-2):103-7. PubMed ID: 1428958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
    Selker RG; Shapiro WR; Burger P; Blackwood MS; Arena VC; Gilder JC; Malkin MG; Mealey JJ; Neal JH; Olson J; Robertson JT; Barnett GH; Bloomfield S; Albright R; Hochberg FH; Hiesiger E; Green S;
    Neurosurgery; 2002 Aug; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Brachytherapy With External Beam Radiation Therapy Versus Brachytherapy Alone for Intermediate-Risk Prostate Cancer: NRG Oncology RTOG 0232 Randomized Clinical Trial.
    Michalski JM; Winter KA; Prestidge BR; Sanda MG; Amin M; Bice WS; Gay HA; Ibbott GS; Crook JM; Catton CN; Raben A; Bosch W; Beyer DC; Frank SJ; Papagikos MA; Rosenthal SA; Barthold HJ; Roach M; Moughan J; Sandler HM
    J Clin Oncol; 2023 Aug; 41(24):4035-4044. PubMed ID: 37315297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10-year outcome for men with localized prostate cancer treated with external radiation therapy: results of a cohort study.
    Zietman AL; Chung CS; Coen JJ; Shipley WU
    J Urol; 2004 Jan; 171(1):210-4. PubMed ID: 14665878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity of photodynamic therapy after combined external beam radiotherapy and intraluminal brachytherapy for carcinoma of the upper aerodigestive tract.
    Sanfilippo NJ; Hsi A; DeNittis AS; Ginsberg GG; Kochman ML; Friedberg JS; Hahn SM
    Lasers Surg Med; 2001; 28(3):278-81. PubMed ID: 11295765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors.
    Schleicher UM; Staatz G; Alzen G; Andreopoulos D
    Strahlenther Onkol; 2002 Dec; 178(12):682-7. PubMed ID: 12491056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
    Poon I; Pintilie M; Potvin M; McGowan T
    Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of combined high-dose-rate brachytherapy and external beam radiotherapy for adenocarcinoma of the prostate: preliminary results of RTOG 0321.
    Hsu IC; Bae K; Shinohara K; Pouliot J; Purdy J; Ibbott G; Speight J; Vigneault E; Ivker R; Sandler H
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):751-8. PubMed ID: 20207506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy of brachytherapy combined with external-beam radiotherapy and repeated arterial infusion chemotherapy in patients with unresectable extrahepatic bile duct cancer.
    Nomura M; Yamakado K; Nomoto Y; Nakatsuka A; Ii N; Shoji K; Takeda K
    Int J Oncol; 2002 Feb; 20(2):325-31. PubMed ID: 11788896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential decreased morbidity of interstitial brachytherapy for gynecologic malignancies using laparoscopy: A pilot study.
    Choi JC; Ingenito AC; Nanda RK; Smith DH; Wuu CS; Chin LJ; Schiff PB
    Gynecol Oncol; 1999 May; 73(2):210-5. PubMed ID: 10329036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.